Evidence map›Paper›PMID 25045619›Full record

ArticleCurrent behavioral neuroscience reports2014

The Genetics, Neurogenetics and Pharmacogenetics of Addiction.

Catherine H Demers, Ryan Bogdan, Arpana Agrawal

Abstract read
In one paragraph

Article in Current behavioral neuroscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Environmental, genetic and epigenetic contributions to cocaine addiction.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catherine H DemersDepartment of Psychology, Washington University in St. Louis, Saint Louis, MO 63130.
Ryan BogdanDepartment of Psychology, Washington University in St. Louis, Saint Louis, MO 63130.
Arpana AgrawalDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO 63110.

Funding

T32 Training Grant in Epidemiology, Services and Prevention ResearchT32DA007313 · NIDA · WASHINGTON UNIVERSITY · PI PRICE, RUMI KATO · 1999 to 2013
$2.9M
CANNABIS AND TOBACCO INVOLVEMENT: A TWIN STUDYR01DA023668 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2007 to 2016
$2.5M
DELINEATING THE ROLE OF GENETIC INFLUENCES ON CANNABIS INVOLVEMENTK02DA032573 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2012 to 2021
$1.1M
AGE AT FIRST DRINK AND ALCOHOLISM: INTERSECTION OF GENES AND ENVIRONMENTR21AA021235 · NIAAA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2013 to 2014
$392k
NIAAA NIH HHS R21 AA021235NIDA NIH HHS K02 DA032573NIDA NIH HHS R01 DA023668NIDA NIH HHS T32 DA007313
6 · The paper itself

Abstract

Addictions are prevalent psychiatric disorders that confer remarkable personal and social burden. Despite substantial evidence for their moderate, yet robust, heritability (approx. 50%), specific genetic mechanisms underlying their development and maintenance remain unclear. The goal of this selective review is to highlight progress in unveiling the genetic underpinnings of addiction. First, we revisit the basis for heritable variation in addiction before reviewing the most replicable candidate gene findings and emerging signals from genomewide association studies for alcohol, nicotine and cannabis addictions. Second, we survey the modest but growing field of neurogenetics examining how genetic variation influences corticostriatal structure, function, and connectivity to identify neural mechanisms that may underlie associations between genetic variation and addiction. Third, we outline how extant genomic findings are being used to develop and refine pharmacotherapies. Finally, as sample sizes for genetically informed studies of addiction approach critical mass, we posit five exciting possibilities that may propel further discovery (improved phenotyping, rare variant discovery, gene-environment interplay, epigenetics, and novel neuroimaging designs).

Indexed as

AddictionADH1BCNR1GABRA2GeneticsNeurogeneticsPharmacogeneticsrs16969968

Identifiers

PMID25045619
PMCPMC4097314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.